APA (7th ed.) Citation

SW, B., & JE, A. (2018). The pharmacokinetic advantage of 5-methyltetrahydrofolate for minimization of the risk for birth defects. Scientific reports, 8(1), 4096. https://doi.org/10.1038/s41598-018-22191-2

Chicago Style (17th ed.) Citation

SW, Bailey, and Ayling JE. "The Pharmacokinetic Advantage of 5-methyltetrahydrofolate for Minimization of the Risk for Birth Defects." Scientific Reports 8, no. 1 (2018): 4096. https://doi.org/10.1038/s41598-018-22191-2.

MLA (9th ed.) Citation

SW, Bailey, and Ayling JE. "The Pharmacokinetic Advantage of 5-methyltetrahydrofolate for Minimization of the Risk for Birth Defects." Scientific Reports, vol. 8, no. 1, 2018, p. 4096, https://doi.org/10.1038/s41598-018-22191-2.